ConductScience.org, home

Trial · NCT04533997

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

NCT04533997, Phase 3, Completed, Puerta de Hierro University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Hypertonic Saline Therapy in Ambulatory Heart Failure Unit. Trials, record NCT04533997. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04533997

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
NCT number
NCT04533997
Status
Completed
Phases
Phase 3
Enrollment
167 participants, actual
Lead sponsor
Puerta de Hierro University Hospital
Conditions
Heart Failure
Interventions
Hypertonic saline solution plus intravenous furosemide, Intravenous furosemide
First posted
2020-09-01
Last updated
2023-11-09

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDiuresis volume (ml)3 hours after treatmentTotal diuresis volume after 3 hours of therapy administration
SecondaryWeight difference (kg)3 hoursDifference of weight 3 hours after the start of treatment
SecondaryWeight difference (kg)7 daysDifference of weight 7 days after the start of treatment
SecondaryChange in composite congestion score7 daysComposite of orthopnoea (0-3), jugular venous distension (0-3), lower limb oedema (0-3). Higher score: worse congestion
SecondaryChange in Inferior cava vein diameter (mm)7 daysChange in Inferior cava vein diameter (mm) 7 days after treatment
SecondaryChange in Number of fields with more than 3 B-lines in lung ultrasound7 daysChange in Number of fields with more than 3 B-lines in lung ultrasound 7 days after treatment
SecondaryChange in New York Heart Association and Visual Analogue Scale7 daysVisual Analogue Scale from 0 (worst state of health) to 100 (best state of health)
SecondaryChange in NTproBNP and Cancer Antigen 125 levels7 daysChange in NTproBNP and Cancer Antigen 125 levels 7 days after treatment
SecondaryChange in Hemoconcentration Parameters7 daysHematocrit, Albumin and total Proteins
SecondaryChange in Urinary Sodium7 daysChange in Urinary Sodium measured in a spot urinary sample

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04533997

GET https://conductscience.org/api/trials/v1/NCT04533997/registered